TGFB1 and cancer: The inappropriate activation of EMT, mediated by TGF-β signaling, has been implicated in the pathology of various forms of fibrosis [17,18], including cystic fibrosis ([19,20], and cancers that are particularly prone to early metastasis, such as pancreatic ductal adenocarcinoma [16].